Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research.

× No keyword cloud information.

5 in total

1. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

Authors: Shivaram Bhat; Helen G Coleman; Fouad Yousef; Brian T Johnston; Damian T McManus; Anna T Gavin; Liam J Murray
Journal: J Natl Cancer Inst Date: 2011-06-16 Impact factor: 13.506

2. Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results.

Authors: Matthew B Sturm; Bishnu P Joshi; Shaoying Lu; Cyrus Piraka; Supang Khondee; Badih Joseph Elmunzer; Richard S Kwon; David G Beer; Henry D Appelman; Danielle Kim Turgeon; Thomas D Wang
Journal: Sci Transl Med Date: 2013-05-08 Impact factor: 17.956

3. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors: Heiko Pohl; H Gilbert Welch
Journal: J Natl Cancer Inst Date: 2005-01-19 Impact factor: 13.506

4. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis.

Authors: Tusar K Desai; Kumar Krishnan; Niharika Samala; Jashanpreet Singh; John Cluley; Subaiah Perla; Colin W Howden
Journal: Gut Date: 2011-10-13 Impact factor: 23.059

5. Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors: Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal: N Engl J Med Date: 2011-10-13 Impact factor: 91.245

5 in total

3 in total

Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research.

1. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

2. Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results.

3. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

4. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis.

5. Incidence of adenocarcinoma among patients with Barrett's esophagus.

Review 1. A Systematic Review of Esophageal MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus.

2. Barrett Esophagus: Prevalence, Treatment, and the Link to Esophageal Adenocarcinoma.

3. Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.